Antidepressant augmentation: good news, limitations, and stumbling blocks. Article uri icon

Overview

abstract

  • Dr Zhou and colleagues have done an excellent job of reviewing and analyzing the world's literature on the efficacy and tolerability of pharmacologic agents used to augment antidepressants in treatment-resistant unipolar major depression. It seems we have some good news, but a lot remains to be accomplished. The good news is that several agents were found to have significant efficacy in terms of response (4 agents) and remission (6 agents) in comparison to placebo.

publication date

  • April 1, 2015

Research

keywords

  • Antidepressive Agents
  • Depressive Disorder, Major
  • Depressive Disorder, Treatment-Resistant
  • Patient Acceptance of Health Care

Identity

Scopus Document Identifier

  • 84932091924

Digital Object Identifier (DOI)

  • 10.4088/JCP.14com09536

PubMed ID

  • 25919849

Additional Document Info

volume

  • 76

issue

  • 4